Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GOLIMUMAB Cause Bone density abnormal? 34 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Bone density abnormal have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.1% of all adverse event reports for GOLIMUMAB.

34
Reports of Bone density abnormal with GOLIMUMAB
0.1%
of all GOLIMUMAB reports
1
Deaths
2
Hospitalizations

How Dangerous Is Bone density abnormal From GOLIMUMAB?

Of the 34 reports, 1 (2.9%) resulted in death, 2 (5.9%) required hospitalization, and 1 (2.9%) were considered life-threatening.

Is Bone density abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does GOLIMUMAB Cause?

Drug ineffective (17,959) Rheumatoid arthritis (12,272) Pain (11,443) Fatigue (9,626) Off label use (8,764) Alopecia (8,394) Rash (8,331) Joint swelling (8,264) Arthralgia (7,968) Abdominal discomfort (7,902)

What Other Drugs Cause Bone density abnormal?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,039) DENOSUMAB (643) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (580) ROMOSOZUMAB-AQQG (454) TENOFOVIR DISOPROXIL (310) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (276) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (199) ADALIMUMAB (174) METHOTREXATE (155) TERIPARATIDE (146)

Which GOLIMUMAB Alternatives Have Lower Bone density abnormal Risk?

GOLIMUMAB vs GOLODIRSEN GOLIMUMAB vs GONADORELIN GOLIMUMAB vs GONADOTROPHIN, CHORIONIC GOLIMUMAB vs GOSERELIN GOLIMUMAB vs GRAMICIDIN

Related Pages

GOLIMUMAB Full Profile All Bone density abnormal Reports All Drugs Causing Bone density abnormal GOLIMUMAB Demographics